glutathione stability test system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Total Glutathione Assay

For those experiencing chronic fatigue or unexplained symptoms, our clinicians thoroughly assess for potential vitamin deficiencies, including B12

This offers hope for both new therapeutic avenues for highly prevalent diseases currently treated by other means, and rare diseases with no approved therapies to date

In a statement, the ECHA noted that SEAC acknowledges the need for targeted derogations for specific PFAS uses when this is justified by the available evidence that alternatives are not available as well as by the assessment of costs and benefits, to ensure the restriction remains proportionate. A final decision from SEAC is expected by end-2026

doi: 10.1186/s12958-018-0391-5 125 ShkolnikKTadmorABen-DorSNevoNGalianiDDekelN